Consistent with these findings, VEGF receptor KDR inhibitor cocktail treatment significantly elevated SMAD3 expression compared to vehicle-treated conditions at all time points both in combined analyses and those done separately for AD and controls (Fig. 4f, Supplementary Fig. 21B). Here, SMAD3 is linked to Alzheimer disease.